Addressing Diversity in Alzheimer’s Clinical Trials
A hurdle in developing Alzheimer’s theraputics that work for people of all ethnicities is recruitment & retention of underrepresented groups in clinical trials
The Alzheimer's Association leads the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support.
A hurdle in developing Alzheimer’s theraputics that work for people of all ethnicities is recruitment & retention of underrepresented groups in clinical trials
New research reports associations between COVID-19, and persistent cognitive deficits, including the acceleration of Alzheimer’s disease pathology and symptoms.
Transgender adults in the U.S. are more likely to report worsening memory & depression compared to cisgender adults. According to 2 studies reported at the AAIC
Positive trends in global education will decrease dementia prevalence but trends in smoking, BMI & high blood sugar counteract the decrease.
Improving air quality may improve cognitive function and reduce dementia risk, according to several studies reported this weeks AAIC.
The Alzheimer’s Association is pausing the International Research Grant Program (IRGP) letter of intent submission process – New deadlines for the applications submission process for the IRGP will be confirmed soon.